The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ORGO FINANCIAL STATEMENTS

Organogenesis Holdings Inc — balance sheet, income statement and cash flow trends

ORGOOrganogenesis Holdings Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0200 M400 M20212023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue456.5 M $Gross Profit308.6 M $ · 68%Operating Income-29.1 M $ · -6%Pre-tax Income-34.8 M $ · -8%Net Income to Owners-90.2 M $ · -20%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue456.5 M $+6.3%
Gross Profit308.6 M $-3.6%
Operating Income-29.1 M $—
EBITDA-4.7 M $-816.4%
Net Income to Owners-90.2 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M20212023202420252026

Capital Structure

Q2 2026
Total Assets406.4 M
  • Equity288.1 M $71%
  • Current Liabilities57 M $14%
  • Long-term Liabilities61.4 M $15%

Key Figures

YoY change
Total Assets406.4 M $-11.9%
Total Liabilities118.3 M $+18.4%
Total Equity288.1 M $-20.2%
Cash & ST Investments46.1 M $-36.9%
Total Debt67 M $+64.0%
Net Debt20.9 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-50 M050 M20212023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-20 M020 M32 M $Operating-11.1 M $Investing-47.7 M $Financing-26.9 M $Net Change

Key Figures

YoY change
Operating Cash Flow32 M $—
Capital Expenditures11.1 M $-15.6%
Free Cash Flow20.8 M $—
Dividends Paid8.8 M $+37.6%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ORGO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.